Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professors Mina Fazel, Morten Kringelbach and Mike Browning have been given the title of Professor in the 2021 Recognition of Distinction Exercise at the University of Oxford.

Professors Mina Fazel, Morten Kringelbach and Mike Browning

Mina Fazel, Professor of Child and Adolescent Psychiatry and Clinical Child and Adolescent Psychiatrist in the Department of Children's Psychological Medicine at the Children's Hospital, Oxford University Hospitals NHS Foundation Trust, has been working in the Department of Psychiatry for over 20 years, investigating the needs of the most marginalised and vulnerable adolescents.


'I am delighted and very grateful to now be Professor of Adolescent Psychiatry. I will continue in both my research and clinical work to try and improve the care that we can offer young people at a crucial time in their development. The importance of conducting research into adolescent mental health has never been more evident. Awareness amongst young people and policy makers is helping to demonstrate the need for innovative new research.'

Morten Kringelbach, Professor of Neuroscience, Director of the Centre for Eudaimonia and Human Flourishing and Senior Research Fellow at Linacre College, said:


'In these difficult times, it is a great honour to be able to contribute to the excellent research in Oxford Psychiatry. Working with my wonderful colleagues I hope we will be able to better understand what is needed for human flourishing and how to translate this into more effective treatments.'

Mike Browning, Professor of Computational Psychiatry and Honorary Consultant Psychiatrist, leads the Computational Psychiatry Lab in the Department of Psychiatry.


 'It is an honour to be made a professor in Oxford. Computational techniques have the potential to improve the treatment of patients and I am really excited to be working in this area.'

Professor Belinda Lennox, Head of Department, University of Oxford, said:


'I'd like to wish Mina, Morten and Mike huge congratulations. They each represent the very best in their field of expertise. Their research and the work of the teams they lead not only enhances, but also helps to strengthen the future of psychiatry research, and so it is fitting that they have been recognised with the title of professor.'






Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New Study Shows Simvastatin Can Change the Way People Experience Certain Emotions

This new study examines the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation.

Oxford has Largest Volume of World-Leading Research - REF 2021

Results of the Research Excellence Framework (REF) 2021 for UK universities indicate that Oxford has the largest volume of world-leading research*.

Cathy Creswell Elected Fellow of Academy of Medical Sciences

Cathy Creswell, Professor of Developmental Clinical Psychology, Departments of Psychiatry and Experimental Psychology, University of Oxford, has been elected a Fellow of the Academy of Medical Sciences.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Anxiety Disorders Among Children, Assessment and Working with Families

Anxiety disorders are the most common mental health disorders among children, yet there is limited guidance on the process of assessing child anxiety disorders and sharing diagnostic outcomes with families.

Landmark New Clinical Trial Shows Benefits of Automated Virtual Reality (VR) Treatment for Severe Psychological Problems

The gameChange automated VR program is designed to treat agoraphobia in patients with psychosis. In the largest ever clinical trial of virtual reality for mental health, gameChange especially helped people whose anxiety had previously left them virtually housebound.